article thumbnail

AAFP Represents Members During 2025 Legislative Session

Alabama Academy of Family Physicians

What Happened: The Senate Committee on Finance and Taxation Education did not meet to discuss the bill. Pharmacy benefits managers would be further required to pass on 100 percent of rebates received from drug manufacturers to the health benefit plans for which they provide services.

Insurance 130
article thumbnail

MN Legislative Session 2025: Updates on Health Care Bills

Minnesota Academy of Family Physicians

HOUSE COMMERCE FINANCE AND POLICY COMMITTEE H.F. 2403 ( Representative O’Driscoll ): On Wednesday, March 19, 2025, the House Commerce Finance and Policy Committee heard H.F. The bill was passed by a voice vote and was sent to the Tax Committee. Read a summary of S.F. Read a summary of H.F.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ep. 68: Hidden risks of prescribing GLP-1 drugs with Ericka L. Adler, J.D., of Roetzel & Andress

Physician's Practice

Financial Relationships with Pharmaceutical Companies (00:20:10)** Legal and ethical concerns for physicians with financial ties to GLP-1 drug manufacturers, including anti-kickback laws.

article thumbnail

CMS Hammers Final Nail in the Coffin of International Reference Pricing for Drugs

FDA Law Blog

See section 129001 of the most recent Finance Committee text.) However, the approach has been rejected in the version of the Build Back Better Act that is slowly taking shape in the Senate. (See

Finance 52
article thumbnail

CMS Hammers Final Nail in the Coffin of International Reference Pricing for Drugs

FDA Law Blog

See section 129001 of the most recent Finance Committee text.) However, the approach has been rejected in the version of the Build Back Better Act that is slowly taking shape in the Senate. (See

Finance 40
article thumbnail

Gun Violence Reduction Law Further Extends Moratorium on Trump-Era Rebate Rule

FDA Law Blog

If and when implemented, the amendments will likely force Medicare Part D plans and their PBMs to pass drug manufacturer rebates through to pharmacies to reduce out-of-pocket expenses of Part D enrollees, which would be a dramatic change from current practice.

Finance 52
article thumbnail

CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule

FDA Law Blog

Use of international reference pricing as a target for Medicare to negotiate prices with drug manufacturers appears in H.R. It is possible that CMS will issue a new proposed rule to impose international reference pricing in the future, but it is far more likely that the initiative will move to Congress. 3 , the “Elijah E.

Finance 52